In a phase 3 trial in subjects with obesity or overweight (BMI 27kg/m2), its use for 18 months achieved weight loss of up to 20.9%.87 Conclusions Low-grade inflammation underlies obesity and PsO/HS, and this inflammation has a negative impact on both conditions
"As we focus on our biggest problems and opportunities, we must use technology, including AI, to augment care and help our caregivers
More widespread use of SGLT2i in type 1 diabetes will necessitate implementation of strategies to assess and mitigate DKA risk, including preventative measures, patient education and continuous ketone monitoring, as well as a better understanding of the potential benefits for clinical cardiorenal outcomes, especially in high-risk populations such as people with CKD (Table 2) [46, 47]
doi: 10.1016/j.bbi.2015.03.016 94 JourdiH.HsuY
Without regular supplements and blood tests, patients may develop fatigue, hair loss, anemia, nerve symptoms, or reduced bone density
Dr Zhou undertook the work while he was a researcher in the laboratory of Professor Zhiwei Chen, also at the University of Hong Kong